In the present study, for the first time in literature, we analyzed the predictability of AFP SCORE progression on MVI in a homogeneous population of LT recipients with histologically proven HCC who had AFP SCORE ≤2. This evidence concerns the gene AFP and hepatocellular carcinoma.